221 related articles for article (PubMed ID: 15972307)
21. A guide to antibiotic resistance in bacterial skin infections.
Perera G; Hay R
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial stewardship: application in the intensive care unit.
Owens RC
Infect Dis Clin North Am; 2009 Sep; 23(3):683-702. PubMed ID: 19665090
[TBL] [Abstract][Full Text] [Related]
23. The new treatment paradigm and the role of carbapenems.
Masterton RG
Int J Antimicrob Agents; 2009 Feb; 33(2):105-110. PubMed ID: 18848436
[TBL] [Abstract][Full Text] [Related]
24. Conclusions: the future of antimicrobial therapy - Augmentin and beyond.
Ball P
Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S139-41. PubMed ID: 18029150
[TBL] [Abstract][Full Text] [Related]
25. What is inadequate antibacterial therapy?
Moellering RC
Clin Infect Dis; 2009 Oct; 49(7):1006-8. PubMed ID: 19719418
[No Abstract] [Full Text] [Related]
26. The theory of cycling antibiotic resistance.
Shoja MM; Tubbs RS; Ansarin K; Varshochi M; Farahani RM
Med Hypotheses; 2007; 69(2):467-8. PubMed ID: 17280791
[No Abstract] [Full Text] [Related]
27. Economics of antibiotic resistance.
Sipahi OR
Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
[TBL] [Abstract][Full Text] [Related]
28. Preventing bacterial resistance in surgical patients.
Evans HL; Sawyer RG
Surg Clin North Am; 2009 Apr; 89(2):501-19, x. PubMed ID: 19281897
[TBL] [Abstract][Full Text] [Related]
29. Strategies for managing today's infections.
Carmeli Y
Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():22-31. PubMed ID: 18318876
[TBL] [Abstract][Full Text] [Related]
30. Global resistance trends and the potential impact on empirical therapy.
Isturiz R
Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S201-6. PubMed ID: 19134520
[TBL] [Abstract][Full Text] [Related]
31. Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore.
Hsu LY; Kwa AL; Lye DC; Chlebicki MP; Tan TY; Ling ML; Wong SY; Goh LG
Singapore Med J; 2008 Oct; 49(10):749-55. PubMed ID: 18946605
[TBL] [Abstract][Full Text] [Related]
32. Development of new antibacterials: a laudable aim, but what is the value?
Tillotson GS
Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
[No Abstract] [Full Text] [Related]
33. Development of an automated antibiotic consultant.
Evans RS; Pestotnik SL; Classen DC; Burke JP
MD Comput; 1993; 10(1):17-22. PubMed ID: 8418386
[TBL] [Abstract][Full Text] [Related]
34. The antimicrobial armamentarium: evaluating current and future treatment options.
Bosso JA
Pharmacotherapy; 2005 Oct; 25(10 Pt 2):55S-62S. PubMed ID: 16178676
[TBL] [Abstract][Full Text] [Related]
35. [Surveillance of antibiotic use and resistance].
Meyer E; Gastmeier P
Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):116-20. PubMed ID: 17309019
[TBL] [Abstract][Full Text] [Related]
36. The impact of antibiotic management on resistance.
Bosso JA
Pharmacotherapy; 2004 Dec; 24(12 Pt 2):224S-31S. PubMed ID: 15585452
[TBL] [Abstract][Full Text] [Related]
37. National antibiotic resistance surveillance and control.
Raghunath D
Indian J Med Microbiol; 2010; 28(3):189-90. PubMed ID: 20644302
[No Abstract] [Full Text] [Related]
38. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
[No Abstract] [Full Text] [Related]
39. New developments in carbapenems.
Kattan JN; Villegas MV; Quinn JP
Clin Microbiol Infect; 2008 Dec; 14(12):1102-11. PubMed ID: 19076841
[TBL] [Abstract][Full Text] [Related]
40. Outpatient antibiotic use in the United States: time to "get smarter".
Huttner B; Samore M
Clin Infect Dis; 2011 Oct; 53(7):640-3. PubMed ID: 21890768
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
